Background: The molecular pathogenesis of ccRCC was still unknown. Hence, the ccRCC-associated genes needs to explored.Methods: Three ccRCC expression microarray datasets (GSE14762, GSE66270 and GSE53757) downloaded from gene expression omnibus (GEO) database. The distinguish of expressed genes (DEGs) between ccRCC and normal tissue was discuss and explored. the function of our DEGs was analyzed by Gene Ontology (GO) ,Kyoto Encyclopedia of Genes and Genomes (KEGG) .Then the protein‑protein

more »

... action network (PPI) was established in order to screen the hub genes. Then the expressions of hub genes were identified by oncomine database.The prognostic values of hub genes were analyzed by GEPIA database in ccRCC patients. Result: A total of 137 DREs were analyzed, which including 63 upregulated genes and 74 downregulated genes. According to our result,137 DREs were mainly enriched in 82 functional terms and 24 pathways. 14 highest-scoring genes were screened as hub gene in the PPI network which including 12 upregulated candidate genes and 2 downregulated candidate genes. The result reveals that patients with higher C3 expression related to poor OS, while patients with high expression of CTSS and TLR3 related to better OS. Patients with high C3 and CXCR4 expression had a poor DFS, while ccRCC patients with high expression of TLR3 had better DFS. At last, C3 and CXCR4 were selected to detect the prognosis of patients with ccRCC.Conclusion: The result identified the C3 and CXCR4 as candidate biomarkers and potential therapeutic targets in the molecular mechanism and individual treatment of ccRCC.